Valproic acid topical - Amorepacific

Drug Profile

Valproic acid topical - Amorepacific

Alternative Names: VPA spray - Amorepacific Corporation

Latest Information Update: 10 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amorepacific
  • Class Antiepileptic drugs; Antimigraines; Nootropics; Small molecules
  • Mechanism of Action Glycogen synthase kinase 3 beta inhibitors; Wnt signalling pathway stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Male pattern baldness

Most Recent Events

  • 30 Apr 2016 No recent reports on development identified - Phase-II for Male pattern baldness in South Korea (Topical)
  • 15 Mar 2016 Biomarkers information updated
  • 04 Jun 2012 Seoul National University Hospital & Amorepacific complete enrolment in its phase II trial for Male pattern baldness in South Korea (NCT01548066)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top